Astellas : China Approves Padcev For Treatment Of Locally Advanced Or Metastatic Urothelial Cancer
20/8 05:19
(RTTNews) - Astellas Pharma Inc. (ALPMY, ALPMY) announced that the Center for Drug Evaluation of China's National Medical Products Administration has approved Padcev (enfortumab vedotin) for the treatment of adult patients with locally advanced or metastatic urothelial cancer aft...